Design and synthesis of poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors.: Part 3:: In vitro evaluation of 1,3,4,5-tetrahydro-benzo[c][1,6] and [c][1,7]-naphthyridin-6-ones

被引:27
作者
Ferraris, D [1 ]
Ficco, RP [1 ]
Pahutski, T [1 ]
Lautar, S [1 ]
Huang, S [1 ]
Zhang, J [1 ]
Kalish, V [1 ]
机构
[1] Guilford Pharmaceut Inc, Baltimore, MD 21224 USA
关键词
D O I
10.1016/S0960-894X(03)00465-7
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The 1,3,4,5-tetrahydro-benzo[c][1,6]- and [c][1,7]-napthyridin-6-ones are presented as a potent class of PARP-1 inhibitors. Derivatives of these partially saturated aza-5[H]-phenanthridin-6-ones were designed and synthesized with tertiary amines for salt formation. thus enhancing aqueous solubility, iv formulation and their potential use in acute ischemic injuries (i.e., myocardial ischemia and stroke). We found that partial saturation of the C-ring results in derivatives that are several times more potent than the aromatic C-ring derivatives. The general synthetic routes are presented herein as well as thorough in vitro potencies and SAR discussion for selected derivatives. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2513 / 2518
页数:6
相关论文
共 14 条
[1]   Inhibition of caspase-3-mediated poly(ADP-ribose) polymerase (PARP) apoptotic cleavage by human PARP autoantibodies and effect on cells undergoing apoptosis [J].
Decker, P ;
Isenberg, D ;
Muller, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) :9043-9046
[2]  
FERRARIS D, 2003, IN PRESS J MED CHEM
[3]   DNA repair: PARP - another guardian angel? [J].
Jeggo, PA .
CURRENT BIOLOGY, 1998, 8 (02) :R49-R51
[4]   Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: Design, synthesis, and X-ray cocrystal structure [J].
Koch, SSC ;
Thoresen, LH ;
Tikhe, JG ;
Maegley, KA ;
Almassy, RJ ;
Li, JK ;
Yu, XH ;
Zook, SE ;
Kumpf, RA ;
Zhang, C ;
Boritzki, TJ ;
Mansour, RN ;
Zhang, KE ;
Ekker, A ;
Calabrese, CR ;
Curtin, NJ ;
Kyle, S ;
Thomas, HD ;
Wang, LZ ;
Calvert, AH ;
Golding, BT ;
Griffin, RJ ;
Newell, DR ;
Webber, SE ;
Hostomsky, Z .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (23) :4961-4974
[5]   Synthesis of substituted 5[H]phenanthridin-6-ones as potent poly(ADP-ribose)polymerase-1 (PARP1) inhibitors [J].
Li, JH ;
Serdyuk, L ;
Ferraris, DV ;
Xiao, G ;
Tays, KL ;
Kletzly, PW ;
Li, WX ;
Lautar, S ;
Zhang, J ;
Kalish, VJ .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (13) :1687-1690
[6]   SYNTHESIS OF PANCRATISTATIN MODELS [J].
LOPES, RSC ;
LOPES, CC ;
HEATHCOCK, CH .
TETRAHEDRON LETTERS, 1992, 33 (45) :6775-6778
[7]   Activation of poly(ADP-Ribose) polymerase in the rat hippocampus may contribute to cellular recovery following sublethal transient global ischemia [J].
Nagayama, T ;
Simon, RP ;
Chen, DX ;
Henshall, DC ;
Pei, W ;
Stetler, RA ;
Chen, J .
JOURNAL OF NEUROCHEMISTRY, 2000, 74 (04) :1636-1645
[8]   Selective α-1A adrenergic receptor antagonists.: Effects of pharmacophore regio- and stereochemistry on potency and selectivity [J].
Patane, MA ;
DiPardo, RM ;
Price, RP ;
Chang, RSL ;
Ransom, RW ;
O'Malley, SS ;
Di Salvo, J ;
Bock, MG .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (18) :2495-2500
[9]   VINYL ISOCYANATES IN SYNTHESIS - [4+2] CYCLO-ADDITION REACTIONS WITH BENZYNE ADDENDS [J].
RIGBY, JH ;
HOLSWORTH, DD ;
JAMES, K .
JOURNAL OF ORGANIC CHEMISTRY, 1989, 54 (17) :4019-4020
[10]   Random mutagenesis of the poly(ADP-ribose) polymerase catalytic domain reveals amino acids involved in polymer branching [J].
Rolli, V ;
OFarrell, M ;
MenissierdeMurcia, J ;
deMurcia, G .
BIOCHEMISTRY, 1997, 36 (40) :12147-12154